Salute e Benessere

Global Machine to Machine (M2M) Healthcare Market Set to Reach USD 35.30 Billion…

Revolutionizing Healthcare through M2M Technology Revolutionizing Healthcare through M2M Technology Machine-to-machine (M2M) healthcare signifies the convergence of interconnected devices and sensors within the healthcare sector, facilitating the seamless collection, transmission, and analysis of data without the need for direct human intervention. This transformative technology fosters the fluid exchange of information among medical devices, patient monitoring systems, and healthcare...
PR Newswire
12/10/2023

IoT in Healthcare Market to Reach USD 787.17 Billion by 2030, Driven by Growing…

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1302 To Know More Request a Sample of this Report:https://www.infiniumglobalresearch.com/market-reports/sample-request/1302 Growing Demand for Technological Advancements in the Healthcare Sector are Poised to Create Numerous Opportunities The rising prevalence of chronic diseases, including diabetes, heart conditions, and respiratory ailments among middle-aged and...
PR Newswire
12/10/2023

Neoss® Group receives EU Medical Device Regulation (MDR) certifications for…

This once again demonstrates that Neoss Group is at the forefront of their commitment to ensuring that their products adhere to the highest standards for the benefit of their customers and their patients. They are also one of the first companies in the dental device field to achieve MDR certification for their products. This once again demonstrates that Neoss Group is at the forefront of their commitment to ensuring that their products adhere to the highest standards for the benefit of their...
PR Newswire
12/10/2023

The Global In Vitro Toxicology Testing Market is Poised for Exponential Growth…

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1178 To Know More Request a Sample of this Report:https://www.infiniumglobalresearch.com/market-reports/sample-request/1178 Driving Factors for Market Growth The burgeoning in vitro toxicology testing market is fuelled by several pivotal factors: Challenges and Opportunities While the market shows immense promise, it faces certain challenges: ...
PR Newswire
12/10/2023

Interim dividend payment

Please read the full announcement in PDFAttachment 2023_Interim_dividend
Nasdaq GlobeNewswire
12/10/2023

Prestigious World Congress of Neurology Returns In-Person to Convene World-Class…

This year's Scientific Program will be organized around the theme, "brain health is our greatest wealth." Through a wide range of programming, including scientific sessions, teaching courses and plenary lectures, leading neurologists and global health experts will explore global neurological challenges, and researchers will share their unique insights and collaborate on central issues in neuroscience and brain research. This year's Scientific Program will be organized around the…
PR Newswire
12/10/2023

Global Digital Health Market is Expected to Reach USD 770.26 Billion by 2030…

Revolutionizing Healthcare Through Digital Innovation Revolutionizing Healthcare Through Digital Innovation Digital health is poised to revolutionize healthcare by preventing diseases, reducing costs, and empowering patients to manage chronic conditions effectively. It has the potential to deliver personalized medicine and provides healthcare providers with a comprehensive view of patients suffering from chronic or other diseases. Leveraging big data analytics, digital health has empowered...
PR Newswire
12/10/2023

Midea RAC Thailand Factory delivered 1 Millionth AC Set, Opening a New Chapter…

Since passing the milestone of exporting its millionth unit in 2003, Midea RAC can export more than 30 million units annually. In 2022, Midea ranked No.1 in China by domestic sales and exports and globally by sales of the eco-friendly R290 series. Since passing the milestone of exporting its millionth unit in 2003, Midea RAC can export more than 30 million units annually. In 2022, Midea ranked No.1 inChinaby domestic sales and exports and globally by sales of the eco-friendly R290 series...
PR Newswire
12/10/2023

Southeast Asia and India slated to be luxury beauty's most lucrative growth…

In contrast to China, Japan, Singapore, and South Korea, other markets in SEA and India are relatively unsaturated, with limited presence of both international luxury beauty brands and compelling local ones, and significant upside potential for luxury beauty spend per capita. As these economies mature, the upper- and middle-classes are projected to surpass 1 billion people in 2026[2], with more consumers expected to trade up from mass to luxury. Thus, this presents a limited but golden window of…
PR Newswire
12/10/2023

Bactiguard's coating reduces thrombo-inflammatory reactions and acute stent…

The unique feature of Bactiguard's noble metal coating is that it reduces microbial adhesion on the surface of a medical device. Other studies have previously suggested that the coating also can reduce the thrombo-inflammatory reaction. This specific study on the impact of using Bactiguard's coating to reduce thrombo-inflammatory reactions and acute stent thrombosis was performed to gather even more clinical data and proof points of the coating's efficacy. For innovation and future application…
PR Newswire
12/10/2023

Positive Results for Hexvix Phase III Clinical Trial in China Presented at the…

"This randomized-controlled trial reinforces the benefits of BLC with Hexvix in tumor detection over WLC alone with clinically convincing and statistically significant results. This is on the backdrop of this Chinese trial being the first RCT conducted with 4K high definition (HD) blue light equipment, making it a valuable addition to the body of evidence already available on BLC with Hexvix. It confirms that BLC with Hexvix is additive to WL also with high quality HD imaging technology. We…
PR Newswire
12/10/2023

Alvotech Provides Update on Status of U.S. Biologics License Application for…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Alvotech's Biologics License Application (BLA) for AVT04, a biosimilar candidate to Stelara® (ustekinumab).As expected, the CRL noted that certain deficiencies, which were conveyed following the FDA's inspection of the company's Reykjavik...
Nasdaq GlobeNewswire
12/10/2023

Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of…

Traditionally, drug supply strategies have relied on static quantities of initial drug shipments and buffers, often leading to excessive orders to ensure enough medication is available during a trial. Buffers, a common tool for ensuring adequate medication supply at sites, create average upper and lower limits for medication stock at all trial sites and automatically trigger medication orders if supplies hit the low limit. Traditionally, drug supply strategies have relied on static quantities...
PR Newswire
12/10/2023

Synaffix to Launch New ADC Technologies at the World ADC Conference in San Diego

GlycoConnect™ enables any antibody to be converted into a stable conjugated ADC in a non-genetic fashion, by modifying the native antibody glycan using Synaffix's efficient enzymes and metal-free click chemistry approach. The extension of GlycoConnect™ with High DAR Technology enables ADCs with high drug loading (6, 8 and above), while retaining high drug substance homogeneity and therapeutic index. GlycoConnect™ enables any antibody to be converted into a stable conjugated ADC in a...
PR Newswire
12/10/2023

Chr. Hansen Holding A/S Interim Report Q4 2022/23

October 12, 2023 – Company announcement no. 9Strong performance for the quarter despite a challenging environment Statement by CEO Mauricio Graber: “ Supported by a strong Q4 performance, Chr. Hansen delivered a solid result for the first twelve months of the extended financial year 2022/23 at the upper end of our guidance with 11% organic revenue growth and an EBIT margin b.s.i. of 26.9%. Throughout the year, we have demonstrated the attractiveness of the markets we serve and the...
Nasdaq GlobeNewswire
12/10/2023

Pharming Group to report third quarter 2023 financial results on October 26

Leiden, The Netherlands, October 12, 2023:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023.To participate in the conference call, please register in advance using the link below. Once registered, dial-in...
Nasdaq GlobeNewswire
12/10/2023

Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth…

Mydecine Innovations Group, Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, announces that it has completed its admission to the Access segment of the AQSE Growth Market (“ AQSE ”) and that trading commenced at 8:00 A.M. GMT on Tuesday, 10 October 2023 (" Admission ")…
Nasdaq GlobeNewswire
12/10/2023

Continued strong third quarter performance with 11% topline growth to €191…

Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 October 2023 – 7:00 AM CET Continued strong third quarter performance with 11% topline growth to €191 million Fagron, the leading global player in pharmaceutical compounding today publishes its quarterly results for the period ending 30 September 2023. Key Highlights Solid revenue growth continues with 10.6% reported growth (13.9% at CER) and 10.2% organic growth (13.4% at CER) to €191...
Nasdaq GlobeNewswire
12/10/2023

Ultimovacs Provides 4-Year Update from Phase I Study in Malignant Melanoma…

No confirmed patient deaths occurred in cohort 1 between the 3-year and 4-year follow-up.Oslo, October 12, 2023:Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, today announced encouraging overall survival (OS) data from cohort 1 in the UV1-103 Phase I clinical trial in malignant melanoma. Among the patients in cohort 1 who were alive at the 3-year follow-up, no further deaths have been reported,...
Nasdaq GlobeNewswire
12/10/2023

Press release Biocartis Group NV: Biocartis Announces Expansion of its…

PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations KitMechelen, Belgium, 12 October 2023– Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company and APIS Assay Technologies Ltd. ('APIS'), a private UK based company specializing in molecular diagnostics, today announced the expansion of their partnership 1to include the...
Nasdaq GlobeNewswire
12/10/2023

New data for Roche's OCREVUS show that after 10 years of treatment 77% of people…

10-year efficacy data highlight OCREVUS' impact on preventing disability progression and maintaining mobility in both relapsing and progressive forms of multiple sclerosis (MS)10-year safety data from over 6,000 patients continue to reinforce consistent long-term safety profile of OCREVUSMore than 3,200 women with MS treated with OCREVUS reported no increased risk in adverse pregnancy and infant outcomes with real-world analyses showing low risk of relapse during and after pregnancy...
Nasdaq GlobeNewswire
12/10/2023

Leptomeningeal Metastases Treatment Market to Register Immense Growth by 2032…

Key Takeaways from the Leptomeningeal Metastases Market Report Key Takeaways from the Leptomeningeal Metastases Market Report Discover which therapies are expected to grab the major leptomeningeal metastases market share @Leptomeningeal Metastases Market Report Leptomeningeal Metastases Overview Leptomeningeal metastases, also known as carcinomatous meningitis and neoplastic meningitis, refers to the dissemination of cancerous cells into the cerebrospinal fluid space...
PR Newswire
11/10/2023

Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) / Nasdaq Euronext Compartment: B ISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of Shares OutstandingTotal number of voting rightsTotal voting rights, theoretical 1 Total voting rights,exercisable 2...
Nasdaq GlobeNewswire
11/10/2023

ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update

The webcast will be held on November 16, 2023, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and CFO Khaled Bahi, who will discuss highlights from Q3 2023 and provide a business update. To join the webcast via Zoom, please register using thislink. Participants may also join by phone: +32 2 290 9360 (Belgium) +49 69 3807 9884 (Germany) +31 20 794 0854 (Netherlands) +41 22 591 0156 (Switzerland) +44 203 481 5240 (United Kingdom) +1 346 248...
Nasdaq GlobeNewswire
11/10/2023
Altri  Comunicati